Since, SDH and FH mutations are related to the progression of many cancers, including paraganglioma, RCC, pheochromocytoma, and endocrinecancers [147,148,149,150], investigation of the Vit-C therapy warranted for these mutant cells resulted in suppression of HIF activity and decreased tumor growth and development in vivo studies. The gene discussed is FH; the disease is cancer.